课题基金 / 基金详情

Invasiveness of malignant glioma and lipoprotein receptor related protein

Invasiveness of malignant glioma and lipoprotein receptor related protein
恶性胶质瘤的侵袭性与脂蛋白受体相关蛋白
批准号:
09671459
负责人:
YAMAMOTO Masaaki
金额:
$0.7万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

YAMAMOTO Masaaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Low density lipoprotein receptor-related protein (LRP) plays an important role in regulating proteinase activity, which is necessary for cellular invasive processes. In this study, we investigated the presence of both LRP and urokinase-type plasminogen activator receptor (uPAR) in astrocytoma tissues and in glioma cell lines by polymerase chain reaction and immunohistochemical analysis. LRP mRNA was frequently expressed in glioblastomas, as compared with low-grade astrocytomas by polymerase chain reaction analysis, and was correlated with uPAR expression. These results were consistent with the immunohistochemical localization of LRP protein in glioblastomas. Immunohistochemistry of LRP on sequential frozen sections showed that neoplastic glial cells and endothelial cells of glioblastomas exhibited intense LRP immunoreactivity, while LRP was almost undetectable in low-grade astrocytomas, or in normal glial cells and endothelial cells of normal brain tissues. In normal brain tissues, LRP immunoreactivity was identified in her places.ebral cortex. U105MG cell line, which did not express LRP, was transfected LRP cDNA.This LRP positive U1O5MG (U1O5MG LRP+) showed increased invasiveness compared with U105MG by Matrigel in vitro invasion assay. These results indicate that LRP is overexpressed in malignant astrocytomas, especially in glioblastomas, and the increased expression of LRP appears to correlate with the expression of uPAR and the malignancy of astrocytomas. Our results strongly suggest that LRP may play a role in facilitating glioblastoma invasiveness and neovascularization within tumor tissues by regulating cell surface proteolytic activity.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Masaaki Yamamoto,et.al: "Expression and cellulen localigation of low dmsity topoprotein receptor rdated protein/α2-macroglobnlin receptor in human gliotlosties in vivo" Brain Yuma Pathology. (発表予定).
Masaaki Yamamoto 等人:“体内人神经胶质细胞中低密度拓扑蛋白受体相关蛋白/α2-巨球蛋白受体的表达和细胞定位”Brain Yuma Pathology(待提交)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masaaki Yamamoto,et.al: "Increased expression of low density lipoprotein recepta-related prrtein/α2・masroglobulin Receptor in human madliguant artrocextume" Concer Research. 57. 2799-2805 (1997)
Masaaki Yamamoto 等人:“人 Madliguant artrocextume 中低密度脂蛋白受体相关蛋白/α2·masroglobulin 受体的表达增加”Concer Research 57. 2799-2805 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masaaki Yamamoto et al.: "Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human..." Cancer Research. 57. 2799-2805 (1997)
Masaaki Yamamoto 等人:“人类低密度脂蛋白受体相关蛋白/α2-巨球蛋白受体的表达增加......”癌症研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masaaki Yamamoto, Kohichi Ikeda, Kohichi Ohshima, Hitoshi Tsugu, Hideo Kimura, Masamichi Tomonaga: "Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignat astrocytomas." Cancer Research. 57
Masaaki Yamamoto、Kohichi Ikeda、Kohichi Ohshima、Hitoshi Tsugu、Hideo Kimura、Masamichi Tomonaga:“人类恶性星形细胞瘤中低密度脂蛋白受体相关蛋白/α2-巨球蛋白受体的表达增加。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
the effect of the palatal augmentation prosthesis in cerebrovascular disorder patients
  • 批准号:
    24792080
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.66万
  • 财政年份:
    2012
  • 负责人:
    YAMAMOTO Masaaki
  • 依托单位:
The factor affecting the using of palatal augmentation prosthesis in swallowing.
  • 批准号:
    22791884
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.58万
  • 财政年份:
    2010
  • 负责人:
    YAMAMOTO Masaaki
  • 依托单位:
Research on Criminal sanctions of Antitrust laws
Development of new treatment fr malignant astrocytoma using antiproteolytic activities.
  • 批准号:
    15591557
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2003
  • 负责人:
    YAMAMOTO Masaaki
  • 依托单位:
国内基金
海外基金
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
  • 批准号:
    82372327
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    马展
  • 依托单位:
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
  • 批准号:
    82304565
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    李瑾
  • 依托单位:
miR-7联合miR-17-5P小RNA干扰片段共同阻遏胶质母细胞瘤G1/S转化的研究
  • 批准号:
    81000901
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    刘晓智
  • 依托单位:
变异型IκBα抑制人类胶质瘤的分子机制
  • 批准号:
    30440016
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2004
  • 负责人:
    吴建梁
  • 依托单位: